SonoThera
52 employees
Biotech/Pharma
Series A · $60.8M
Open positions (3)
Company details
Team Size52
IndustryBiotech/Pharma
Funding
Total raised
$60.8M
Last stage
Series A
Investors
Johnson & Johnson Innovation – JJDC
Total raised
$60.8M
Last stage
Series A
Investors
Michael Davidson
Cardiologist and co-founder of SonoThera. Recognized the potential of microbubbles for gene delivery alongside Steve Feinstein.
Steve Feinstein
Cardiologist who invented the first two FDA-approved ultrasound contrast agents (microbubbles). Pioneer in applying microbubbles to gene therapy delivery.
Kenneth Greenberg
PhD in Visual Neuroscience from UC Berkeley. Has 20+ years of biotech experience in gene therapy and drug discovery. Previously co-founded Oncorus and CODA Biotherapeutics, and led external innovation at Janssen/J&J.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.